
|Articles|April 5, 2022
Daily Medication Pearl: Atorvastatin Calcium (Lipitor)
Author(s)Saro Arakelians, PharmD
Lipitor is an inhibitor of HMG-CoA reductase indicated as an adjunct therapy to diet to treat high cholesterol and triglyceride levels.
Advertisement
Indication: Lipitor is an inhibitor of HMG-CoA reductase (statin) indicated as an adjunct therapy to diet to treat high cholesterol and triglyceride levels and reduce the risk of myocardial infarction, stroke, revascularization procedures, and angina in patients without coronary heart disease, but with multiple risk factors.
Insight:
- Dosing: Dose range 10 to 80 mg once daily.
- Dosage forms: 10, 20, 40, and 80 mg tablets
- Adverse events: The most reported adverse events (incidence ≥ 2%) in patients treated with Lipitor in placebo-controlled trials regardless of causality were nasopharyngitis, arthralgia, diarrhea, pain in extremity, and urinary tract infection.
- Mechanism of action: Lipitor is a selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3 methylglutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol.
- Manufacturer: Pfizer
Source:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
2
Therapeutic Cancer Vaccines: Are We There Yet?
3
Amivantamab Shows 45% Response Rate in Pretreated Head and Neck Cancer: OrigAMI-4 Findings
4
EV-303 Trial Shows Unprecedented Survival Benefit With Enfortumab Vedotin Plus Pembrolizumab in Cisplatin-Ineligible Bladder Cancer
5